Cells from patients’ blood could be developed as treatments for heart and circulatory diseases.
Scientists have shed light on a common bleeding disorder by growing and analysing stem cells from patients’ blood to discover the cause of the disease in individual patients.
The technique may enable doctors to prescribe more effective treatments according to the defects identified in patients’ cells.
In future, this approach could go much further: these same cells could be grown, manipulated, and applied as treatments for diseases of the heart, blood and circulation, including heart attacks and haemophilia.
The study focused on von Willebrand disease (vWD), which is estimated to affect 1 in 100 people and can cause excessive, sometimes life-threatening bleeding. vWD is caused by a deficiency of von Willebrand factor (vWF), a blood component involved in making blood clot. vWF is produced by endothelial cells, which line the inside of every blood vessel in our body. Unfortunately, they are difficult to study because taking biopsies from patients is invasive and unpleasant.
A group led by Dr Anna Randi at the National Heart and Lung Institute,Imperial College London used a new approach to investigate the disease. Dr Richard Starke, a British Heart Foundation Intermediate Fellow and lead author of the study, took routine blood samples from eight patients with vWD, extracted stem cells called endothelial progenitor cells, and grew them in the lab to yield large numbers of endothelial cells.
By testing these cells, they were able to analyse each patient’s disease in unprecedented detail. In some patients, the scientists found new types of defect, which may enable them to recommend improved treatments. Professor Mike Laffan, a collaborator in the study and in charge of patients with VWD at Hammersmith Hospital in West London, is looking to apply these findings to reduce severe bleeding in these patients.
Dr Randi believes that endothelial progenitor cells could become an invaluable resource for testing new drugs for vWD and other diseases. “We will be able to test the effects of a range of compounds in the patients’ own cells, before giving the drugs to the patients themselves,” she said.
This approach could have impact far beyond vWD. Endothelial cells derived from blood could also be isolated and reinjected into someone recovering from a heart attack, to help them grow new blood vessels and repair the injured heart tissue. Dr Starke says this approach avoids the main problem with transplant therapies, in which the immune system tries to destroy the foreign material. “The patients would receive their own cells, so they wouldn’t face the problems of rejection,” he said.
Work is well underway towards achieving this goal, but blood-derived endothelial cells are only now being explored. “There are already many studies where patients have been injected with stem cells to see whether damage to the heart could be repaired, and there are some promising results,” says Dr Randi. “The door is open to such treatments, and our studies are a step towards identifying the right cells to use.”
The Latest Bing News on:
Stem cell therapy
- 'Oxygen can heal': Hyperbaric chamber treatment offers breakthrough solution for long COVID-19on May 9, 2024 at 2:31 pm
Although we may not hear much about it these days, long COVID-19 is still out there. In the beginning, treatment seemed to be a hit-and-miss, but the approach has had a breakthrough.Lynette Malkovich ...
- New treatment could reverse hair loss caused by an autoimmune skin diseaseon May 9, 2024 at 1:21 pm
Researchers developed a potential new treatment for alopecia areata, an autoimmune disorder that causes hair loss. The microneedle patch delivers immune-regulating molecules that can teach T cells not ...
- Stem cell treatments in Mexico linked to drug-resistant meningitis, joint infectionson May 9, 2024 at 12:35 pm
Antibiotic-resistant meningitis or severe, long-lasting joint infections: That's what three U.S. "medical tourists" brought home after seeking out unapproved stem cell treatments in Mexico, according ...
- Researchers identify highly drug-resistant infections from stem cell treatments in Mexicoon May 9, 2024 at 11:30 am
Experts in mycobacterial diseases at National Jewish Health, in collaboration with local health departments and the Centers for Disease Control and Prevention (CDC), are investigating a potential ...
- Stem cell injections in Mexico can be hazardous. Report identifies US victims.on May 9, 2024 at 10:19 am
Two cases of bacterial infection shared identical genetic material even thought the procedures took place hundreds of miles apart.
- Cells collected from 1st SCD patient receiving gene therapy Lyfgeniaon May 9, 2024 at 9:53 am
Lyfgenia is a one-time gene therapy approved last year by the FDA to treat sickle cell patients, 12 and older, with a history of VOEs.
- Supercharging immune cells to battle blood cancer: Advances in cancer immunotherapyon May 9, 2024 at 6:51 am
Cancer has a profound impact on human life, and immune checkpoint therapy (ICT) has made remarkable strides in cancer treatment. However, ICT faces challenges such as low overall response rates and ...
- Lisata’s Autologous T Cell Therapy is Safe but Fails to Slow T1D Disease Progression, Trial Findson May 9, 2024 at 6:34 am
An autologous and personalized regulatory T cell therapy is safe in patients with type 1 diabetes, but does not help preserve β-cell function.
- As Ozzy Osbourne announces stem cell therapy, experts urge caution, highlight riskson May 9, 2024 at 2:00 am
As rock legend Ozzy Osbourne has turned to stem cell therapy, some experts caution that the treatment is not for everyone. A doctor weighed in on the potential risks.
- When Happy Pills Fail, This Treatment May Help You Turn a Corneron May 8, 2024 at 5:00 pm
The treatment involves delivering brief magnetic pulses to the brain via an electromagnetic coil applied to the patient’s head. This induces electrical currents that stimulate nerve cells in specific ...
The Latest Google Headlines on:
Stem cell therapy
[google_news title=”” keyword=”stem cell therapy” num_posts=”10″ blurb_length=”0″ show_thumb=”left”] [/vc_column_text]The Latest Bing News on:
Personalized medicine
- The Role of Data Science in Revolutionizing Personalized Medicine and Drug Discoveryon May 9, 2024 at 1:49 am
Genomic data holds immense promise in personalized medicine. Advances in DNA sequencing technologies have made it possible to decode an individual's entire genome, uncovering genetic variations that ...
- Global Companion Diagnostics Research Report 2024-2029: Innovations in Companion Diagnostics Boost Drug Development and Personalized Medicineon May 9, 2024 at 12:43 am
Factors such as the increasing importance of companion diagnostics in drug development, rising cancer incidence, and the growing adoption of targeted therapies are driving market growth.
- Biocartis and Merck to Collaborate on Improving Patient Access to Personalized Medicine in Middle East and North Africa (MEA) Regionon May 7, 2024 at 8:56 am
Biocartis (Mechelen, Belgium) announced an expansion of its collaboration with Merck Serono Middle East and Merck Saudi Ltd., both affiliates of Merck KGaA (“Merck”). The collaboration aims to improve ...
- Study finds personalized antibiotics, prebiotics, and probiotics combo may help treat IBSon May 6, 2024 at 8:00 pm
A study presented at the European Society of Clinical Microbiology and Infectious Diseases conference revealed that over a third of patients treated with a precision approach to post-infectious ...
- OM1 Launches Three New Products Powered by Patented AI Platform to Expedite Delivery of Personalized Medicineon May 6, 2024 at 6:00 am
OM1 Orion, OM1 Lyra, and OM1 Polaris powered by PhenOMTM – an artificial intelligence-powered digital phenotyping platform for personalized medicine and clinical research. OM1 is the leader in ...
- Can a personalized antibiotics, prebiotics, and probiotics combo help treat IBS?on May 4, 2024 at 11:00 pm
A pilot study suggests that a personalized combination of antibiotics, prebiotics, and probiotics may help treat the symptoms of post-infectious irritable bowel syndrome (IBS).
- Molecular Profiling and Companion Diagnostics: Where is Personalized Medicine in Cancer Heading?on May 4, 2024 at 5:00 pm
The goal of personalized medicine is to use the right drug at the right dose – with minimal or no toxicity – for the right patient at the right time. Recent advances in understanding cell ...
- 'Despite promise, personalized medicine for head and neck cancers facing hurdles'on April 26, 2024 at 3:45 am
Improved efficacy: By identifying specific mutations driving tumour growth, personalized medicine allows for targeted therapies that have a higher success rate compared to ‘one-size-fits-all’ ...
- Readers respond to OTC antidepressants, personalized medicine, restoring trust in public health, and moreon April 12, 2024 at 5:00 pm
This essay supports my assertion that the fiscal issues that might hinder the usefulness of personalized medicine need to be dealt with at the same time as we continue our progress towards large ...
- Navigating the maze of cancer: How precision medicine unravels the unknownon March 22, 2024 at 6:30 am
In our journey to unravel the obscurities of high-grade gastroenteropancreatic neuroendocrine neoplasms (GEP-NENs), we've embarked on a quest guided by personalized medicine principles. Imagine you're ...
The Latest Google Headlines on:
Personalized medicine
[google_news title=”” keyword=”personalized medicine” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]